Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05593653
PHASE4
Efficacy of Suvorexant in the Treatment of Insomnia in Midlife Women With Pre-Diabetes
Sponsor: Brigham and Women's Hospital
View on ClinicalTrials.gov
Summary
The aim of this study is to determine if suvorexant can help treat the severity of insomnia in midlife women who are pre-diabetic.
Official title: Treating Insomnia and Improving Glycemic Control in Midlife Women With Insomnia and Pre-diabetes
Key Details
Gender
FEMALE
Age Range
40 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
61
Start Date
2023-01-06
Completion Date
2025-12-31
Last Updated
2025-07-25
Healthy Volunteers
No
Interventions
DRUG
Suvorexant
20mg taken at bedtime for 4 weeks
DRUG
Placebo
placebo taken at bedtime for 4 weeks
Locations (1)
Brigham and Women's Hospital
Boston, Massachusetts, United States